Cargando…

Bioactive Virus-Mimicking Nanovesicles From Dendrimersomes: A Novel Approach to Understanding SARS-CoV-2 Host-Interactions to Better Design Therapeutics

Detalles Bibliográficos
Autor principal:	Javed, Bilal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472522/ https://www.ncbi.nlm.nih.gov/pubmed/32974384 http://dx.doi.org/10.3389/fmolb.2020.00188

Ejemplares similares

Structural understanding of SARS-CoV-2 virus entry to host cells
por: Le, Kim, et al.
Publicado: (2023)

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
por: Bharadwaj, Shiv, et al.
Publicado: (2021)

SARS-CoV-2 Proteins Exploit Host’s Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways
por: Khan, Md. Abdullah-Al-Kamran, et al.
Publicado: (2021)

Editorial: Interaction of Biomolecules and Bioactive Compounds With the SARS-CoV-2 Proteins: Molecular Simulations for the Fight Against Covid-19
por: Falconi, Mattia, et al.
Publicado: (2022)

PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection
por: Lekshmi, V. S., et al.
Publicado: (2023)

Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect
por: Branca, Jacopo Junio Valerio, et al.
Publicado: (2021)

Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites
por: Sheng, Ying, et al.
Publicado: (2022)

Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
por: Yue, Jingwen, et al.
Publicado: (2021)

ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?
por: Pagliari, Francesca, et al.
Publicado: (2020)

Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection
por: Zhong, Yichen, et al.
Publicado: (2022)

Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets
por: Saito, Masaki, et al.
Publicado: (2023)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021)

Helminth Glycans at the Host-Parasite Interface and Their Potential for Developing Novel Therapeutics
por: Bunte, Myrna J. M., et al.
Publicado: (2022)

In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine
por: Masoomi Nomandan, Seyedeh Zeinab, et al.
Publicado: (2022)

Bioactive cell-like hybrids from dendrimersomes with a human cell membrane and its components
por: Yadavalli, Srujana S., et al.
Publicado: (2019)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
por: Xie, Yixin, et al.
Publicado: (2020)

Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2
por: Sobitan, Adebiyi, et al.
Publicado: (2021)

Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation
por: Samad, Abdus, et al.
Publicado: (2023)

Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic
por: Yu, Mingjia, et al.
Publicado: (2021)

SARS-CoV-2 Virion Stabilization by Zn Binding
por: Morante, Silvia, et al.
Publicado: (2020)

Drug Weaponry to Fight Against SARS-CoV-2
por: Cabezón, Elena, et al.
Publicado: (2020)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Modeling of the thermal properties of SARS-CoV-2 S-protein
por: Niu, Ziyuan, et al.
Publicado: (2022)

Aquaporins as Targets of Dietary Bioactive Phytocompounds
por: Tesse, Angela, et al.
Publicado: (2018)

Editorial: Bioactive sphingolipids in health and disease
por: Aslan, Mutay, et al.
Publicado: (2022)

Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
por: Fernández-Quintero, Monica L., et al.
Publicado: (2021)

Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
por: Barberis, Elettra, et al.
Publicado: (2021)

Editorial: Understanding Protein Dynamics, Binding and Allostery for Drug Design
por: Hu, Guang, et al.
Publicado: (2021)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment
por: Pirone, Luciano, et al.
Publicado: (2020)

Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin
por: Miotto, Mattia, et al.
Publicado: (2021)

Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection
por: Huang, Jiahao, et al.
Publicado: (2022)

Phase Separation Drives SARS-CoV-2 Replication: A Hypothesis
por: Vandelli, Andrea, et al.
Publicado: (2022)

Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues
por: Feng, Qiushi, et al.
Publicado: (2020)

Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line
por: Dolskiy, Alexander A., et al.
Publicado: (2020)

Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
por: Mariano, Giuseppina, et al.
Publicado: (2020)

SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan
por: Khan, Adnan, et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development
por: Malik, Yashpal S., et al.
Publicado: (2021)

CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2
por: Shademan, Behrouz, et al.
Publicado: (2022)

In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2
por: Milanetti, Edoardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5d34dvjvui844nl6f0kv3rqs0j